DVA Revenue 2026
Annual and quarterly sales data for DaVita HealthCare Partners Inc
Latest Annual Revenue
$12.82B
2024-12-31
YoY Growth
+5.6%
vs. previous year
4-Year CAGR
44.9%
compound growth
Annual Revenue History
2024-12-31
$12.82B
YoY Growth
+5.6%
2023-12-31
$12.14B
YoY Growth
+4.6%
2022-12-31
$11.61B
YoY Growth
-0.1%
2021-12-31
$11.62B
YoY Growth
+299.9%
2020-12-31
$2.91B
Quarterly Revenue Breakdown
2025-09-30
$3.42B
2025-06-30
$3.38B
2025-03-31
$3.22B
2024-09-30
$3.26B
2024-06-30
$3.19B
2024-03-31
$3.07B
2023-09-30
$3.12B
2023-06-30
$3.00B
Revenue by Segment
Get Full DVA Financial Analysis
View complete income statements, balance sheets, and AI-powered insights
Frequently Asked Questions
What is DVA's revenue?
DVA (DaVita HealthCare Partners Inc) reported $12.82 billion in revenue for 2024-12-31. This represents a 5.6% increase compared to the previous year.
How much revenue does DVA make per year?
DaVita HealthCare Partners Inc generates approximately $12.82 billion in annual revenue based on the most recent fiscal year ending 2024-12-31.
Is DVA revenue growing?
Yes, DVA's revenue is growing. The company achieved 5.6% revenue growth year-over-year. Over the past 4 years, revenue has grown at a compound annual growth rate (CAGR) of 44.9%.
What is DVA's quarterly revenue?
DVA reported $3.42 billion in revenue for the most recent quarter (2025-09-30). This is 1.2% higher than the previous quarter.
What are DVA's revenue sources?
DVA's revenue comes from multiple segments: Total Revenue. See the revenue breakdown below for detailed segment analysis.
How does DVA compare to competitors in revenue?
DVA generates $12.82 billion in annual revenue in the Healthcare sector. Compare DVA to competitors using our stock comparison tool to see relative market share and growth rates.
Disclaimer: Revenue data is based on publicly filed financial statements. Historical performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.